Tumor necrosis factor-alpha and the ERK Pathway drive chemerin expression in response to hypoxia in cultured human coronary artery endothelial cells

Su Kiat Chua, Kou-Gi Shyu, Yuh-Feng Lin, Huey Ming Lo, Bao Wei Wang, Hang Chang, Li-Ming Lien

研究成果: 雜誌貢獻文章

5 引文 (Scopus)

摘要

Background Chemerin, a novel adipokine, plays a role in the inflammation status of vascular endothelial cells. Hypoxia causes endothelial-cell proliferation, migration, and angiogenesis. This study was aimed at evaluating the protein and mRNA expression of chemerin after exposure of human coronary artery endothelial cells (HCAECs) to hypoxia. Methods and Results Cultured HCAECs underwent hypoxia for different time points. Chemerin protein levels increased after 4 h of hypoxia at 2.5% O2 , with a peak of expression of tumor necrosis factor-alpha (TNF-alpha) at 1 h. Both hypoxia and exogenously added TNF-alpha during normoxia stimulated chemerin expression, whereas an ERK inhibitor (PD98059), ERK small interfering RNA (siRNA), or an anti-TNF-alpha antibody attenuated the chemerin upregulation induced by hypoxia. A gel shift assay indicated that hypoxia induced an increase in DNA-protein binding between the chemerin promoter and transcription factor SP1. A luciferase assay confirmed an increase in transcriptional activity of SP1 on the chemerin promoter during hypoxia. Hypoxia significantly increased the tube formation and migration of HCAECs, whereas PD98059, the anti-TNF-alpha antibody, and chemerin siRNA each attenuated these effects. Conclusion Hypoxia activates chemerin expression in cultured HCAECs. Hypoxia-induced chemerin expression is mediated by TNF-alpha and at least in part by the ERK pathway. Chemerin increases early processes of angiogenesis by HCAECs after hypoxic treatment.
原文英語
文章編號e0165613
期刊PLoS One
11
發行號10
DOIs
出版狀態已發佈 - 十月 1 2016

指紋

MAP Kinase Signaling System
Endothelial cells
coronary vessels
endothelial cells
tumor necrosis factor-alpha
hypoxia
Coronary Vessels
Endothelial Cells
Tumor Necrosis Factor-alpha
Cell Hypoxia
Small Interfering RNA
Assays
small interfering RNA
angiogenesis
Adipokines
Antibodies
DNA-Binding Proteins
Cell proliferation
Hypoxia
Luciferases

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

引用此文

Tumor necrosis factor-alpha and the ERK Pathway drive chemerin expression in response to hypoxia in cultured human coronary artery endothelial cells. / Chua, Su Kiat; Shyu, Kou-Gi; Lin, Yuh-Feng; Lo, Huey Ming; Wang, Bao Wei; Chang, Hang; Lien, Li-Ming.

於: PLoS One, 卷 11, 編號 10, e0165613, 01.10.2016.

研究成果: 雜誌貢獻文章

@article{f75bc7e158c14c15bf92d8834778e60e,
title = "Tumor necrosis factor-alpha and the ERK Pathway drive chemerin expression in response to hypoxia in cultured human coronary artery endothelial cells",
abstract = "Background Chemerin, a novel adipokine, plays a role in the inflammation status of vascular endothelial cells. Hypoxia causes endothelial-cell proliferation, migration, and angiogenesis. This study was aimed at evaluating the protein and mRNA expression of chemerin after exposure of human coronary artery endothelial cells (HCAECs) to hypoxia. Methods and Results Cultured HCAECs underwent hypoxia for different time points. Chemerin protein levels increased after 4 h of hypoxia at 2.5{\%} O2 , with a peak of expression of tumor necrosis factor-alpha (TNF-alpha) at 1 h. Both hypoxia and exogenously added TNF-alpha during normoxia stimulated chemerin expression, whereas an ERK inhibitor (PD98059), ERK small interfering RNA (siRNA), or an anti-TNF-alpha antibody attenuated the chemerin upregulation induced by hypoxia. A gel shift assay indicated that hypoxia induced an increase in DNA-protein binding between the chemerin promoter and transcription factor SP1. A luciferase assay confirmed an increase in transcriptional activity of SP1 on the chemerin promoter during hypoxia. Hypoxia significantly increased the tube formation and migration of HCAECs, whereas PD98059, the anti-TNF-alpha antibody, and chemerin siRNA each attenuated these effects. Conclusion Hypoxia activates chemerin expression in cultured HCAECs. Hypoxia-induced chemerin expression is mediated by TNF-alpha and at least in part by the ERK pathway. Chemerin increases early processes of angiogenesis by HCAECs after hypoxic treatment.",
author = "Chua, {Su Kiat} and Kou-Gi Shyu and Yuh-Feng Lin and Lo, {Huey Ming} and Wang, {Bao Wei} and Hang Chang and Li-Ming Lien",
year = "2016",
month = "10",
day = "1",
doi = "10.1371/journal.pone.0165613",
language = "English",
volume = "11",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "10",

}

TY - JOUR

T1 - Tumor necrosis factor-alpha and the ERK Pathway drive chemerin expression in response to hypoxia in cultured human coronary artery endothelial cells

AU - Chua, Su Kiat

AU - Shyu, Kou-Gi

AU - Lin, Yuh-Feng

AU - Lo, Huey Ming

AU - Wang, Bao Wei

AU - Chang, Hang

AU - Lien, Li-Ming

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Background Chemerin, a novel adipokine, plays a role in the inflammation status of vascular endothelial cells. Hypoxia causes endothelial-cell proliferation, migration, and angiogenesis. This study was aimed at evaluating the protein and mRNA expression of chemerin after exposure of human coronary artery endothelial cells (HCAECs) to hypoxia. Methods and Results Cultured HCAECs underwent hypoxia for different time points. Chemerin protein levels increased after 4 h of hypoxia at 2.5% O2 , with a peak of expression of tumor necrosis factor-alpha (TNF-alpha) at 1 h. Both hypoxia and exogenously added TNF-alpha during normoxia stimulated chemerin expression, whereas an ERK inhibitor (PD98059), ERK small interfering RNA (siRNA), or an anti-TNF-alpha antibody attenuated the chemerin upregulation induced by hypoxia. A gel shift assay indicated that hypoxia induced an increase in DNA-protein binding between the chemerin promoter and transcription factor SP1. A luciferase assay confirmed an increase in transcriptional activity of SP1 on the chemerin promoter during hypoxia. Hypoxia significantly increased the tube formation and migration of HCAECs, whereas PD98059, the anti-TNF-alpha antibody, and chemerin siRNA each attenuated these effects. Conclusion Hypoxia activates chemerin expression in cultured HCAECs. Hypoxia-induced chemerin expression is mediated by TNF-alpha and at least in part by the ERK pathway. Chemerin increases early processes of angiogenesis by HCAECs after hypoxic treatment.

AB - Background Chemerin, a novel adipokine, plays a role in the inflammation status of vascular endothelial cells. Hypoxia causes endothelial-cell proliferation, migration, and angiogenesis. This study was aimed at evaluating the protein and mRNA expression of chemerin after exposure of human coronary artery endothelial cells (HCAECs) to hypoxia. Methods and Results Cultured HCAECs underwent hypoxia for different time points. Chemerin protein levels increased after 4 h of hypoxia at 2.5% O2 , with a peak of expression of tumor necrosis factor-alpha (TNF-alpha) at 1 h. Both hypoxia and exogenously added TNF-alpha during normoxia stimulated chemerin expression, whereas an ERK inhibitor (PD98059), ERK small interfering RNA (siRNA), or an anti-TNF-alpha antibody attenuated the chemerin upregulation induced by hypoxia. A gel shift assay indicated that hypoxia induced an increase in DNA-protein binding between the chemerin promoter and transcription factor SP1. A luciferase assay confirmed an increase in transcriptional activity of SP1 on the chemerin promoter during hypoxia. Hypoxia significantly increased the tube formation and migration of HCAECs, whereas PD98059, the anti-TNF-alpha antibody, and chemerin siRNA each attenuated these effects. Conclusion Hypoxia activates chemerin expression in cultured HCAECs. Hypoxia-induced chemerin expression is mediated by TNF-alpha and at least in part by the ERK pathway. Chemerin increases early processes of angiogenesis by HCAECs after hypoxic treatment.

UR - http://www.scopus.com/inward/record.url?scp=84993953302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84993953302&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0165613

DO - 10.1371/journal.pone.0165613

M3 - Article

VL - 11

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 10

M1 - e0165613

ER -